274 results about "Tissue architecture" patented technology

This invention is directed to tissue engineered prostheses made from processed tissue matrices derived from native tissues that are biocompatible with the patient or host in which they are implanted. When implanted into a mammalian host, these prostheses can serve as a functioning repair, augmentation, or replacement body part or tissue structure.

A medical system includes a carrier and a multiplicity of electromechanical transducers mounted to the carrier, the transducers being disposable in effective pressure-wave-transmitting contact with a patient. Energization componentry is operatively connected to a first plurality of the transducers for supplying the same with electrical signals of at least one pre-established ultrasonic frequency to produce first pressure waves in the patient. A control unit is operatively connected to the energization componentry and includes an electronic analyzer operatively connected to a second plurality of the transducers for performing electronic 3D volumetric data acquisition and imaging (which includes determining three-dimensional shapes) of internal tissue structures of the patient by analyzing signals generated by the second plurality of the transducers in response to second pressure waves produced at the internal tissue structures in response to the first pressure waves. The control unit includes phased-array signal processing circuitry for effectuating an electronic scanning of the internal tissue structures which facilitates one-dimensional (vector), 2D (planar), and 3D (volume) data acquisition. The control unit further includes circuitry for defining multiple data gathering apertures and for coherently combining structural data from the respective apertures to increase spatial resolution. When the data gathering apertures are contained in a flexible web or carrier so that the instantaneous positions of the data gathering apertures are unknown, a self-cohering algorithm is used to determine their positions so that coherent aperture combining can be performed.

Disclosed are systems and methods for identifying various tissue structure aspects, such as boundaries of arterial walls, within an image, such as an ultrasound image. Various measurements may be made using information with respect to the identified aspects of tissue structure. For example, intima-media thickness measurements may be made. Additionally or alternatively, tissue structure aspects, such as plaque within an artery, may be characterized, such as by determining a density thereof. Various information, such as measurement datums, used in identification of aspects of tissue structure in one image may be stored and applied to subsequent images, such as images of a video sequence.

Disclosed herein are portable handheld devices, systems, and methods for the evaluation of tissue pathology and the evaluation and/or monitoring of tissue regeneration. The handheld devices and systems perform laser speckle and hyperspectral imaging to assess tissue pathology and tissue regeneration. The device and system of the disclosure may also perform 3D surface reconstruction.

The disclosed embodiments provide a method for acquiring MR data at resolutions down to tens of microns for application in in vivo diagnosis and monitoring of pathology for which changes in fine tissue textures can be used as markers of disease onset and progression. Bone diseases, tumors, neurologic diseases, and diseases involving fibrotic growth and/or destruction are all target pathologies. Further the technique can be used in any biologic or physical system for which very high-resolution characterization of fine scale morphology is needed. The method provides rapid acquisition of signal at selected values in k-space, with multiple successive acquisitions at individual k-values taken on a time scale on the order of microseconds, within a defined tissue volume, and subsequent combination of the multiple measurements in such a way as to maximize SNR. The reduced acquisition volume, and acquisition of only signal values at select places in k-space, along selected directions, enables much higher in vivo resolution than is obtainable with current MRI techniques.

An apparatus for sectioning fresh unfixed tissue into very thin layers with preserved tissue architecture, antigenicity, mRNA content, and amenable to 3-D computer reconstruction without mechanical or thermal damage by employing a sectioning tool having an electrode with an intense focused electrical field at an edge. A computer controlled x-y-z translation stage moves the sectioning tool through the tissue as defined by a predetermined program. The sectioning tool produces consecutive thin sections of fresh tissue for immunohistochemical and nucleic acids analyses without mechanical or thermal damage, ultimately allowing high-resolution volumetric reconstruction of gene and protein expression patterns of large tissue specimens. The geometry of the sectioning tool is selected so as to produce a spatially localized electrical field of sufficient intensity to sever molecular bonds or propagate flaws in tissue without mechanical cutting.

The invention discloses an apparatus and a method for processing tumor image information processing based on digital virtual organ. The apparatus comprises: a body imaging device; image sequence processing device; body organ histomorphology images database; a device for extracting characteristics of healthy persons and patients and merging three dimensional reconstructed multi-model image data; body organization physiological and pathological database and embolism chemotherapy relevant operation simulation software. The method comprises: getting images sequence with organ internal channel information; processing the images sequence and creating virtual organs with organization structure information; extracting characteristics from human organ histomorphology images database and patients' organs image data, having three dimensional re-build multi-model image data merge, and establishing virtual organs.

The invention discloses a graphene oxide porous composite material. The graphene oxide porous composite material comprises the following components in parts by weight: 0.5-4 parts of graphene oxide, 2-8 parts of sodium alginate and 2-8 parts of gelatin. According to the graphene oxide porous composite material disclosed by the invention, a graphene oxide/sodium alginate/gelatin blended sol is prepared, and an irreversible gel formed by exchanging calcium ions with sodium alginate ions is taken as a three-dimensional framework structure of the composite material, so that the obtained porous composite material has the advantages of good mechanical properties, regular tissue structure, high porosity and good biocompatibility, and is expected to be used in a large number of fields, such as water absorption, oil removal, sewage treatment, bio-medicines, tissue engineering, medical dressings and the like.

The present invention is a high resolution, multi-function, conformal electronics device generally having a flexible and stretchable, high-density electrode array, integrated with a catheter (e.g., balloon catheter) for mapping, ablating, pacing and sensing of cardia tissue associated with heart arrhythmias. The active sensing electrode array can acquire diagnostic information including electrical (e.g., electrograms), mechanical (e.g., strain measurements), impedance (e.g., resistance), metabolic (e.g., pH or NADH measurement) from the underlying heart tissue surface with which it is in contact. The electrode array may be designed to be of various sizes and shapes to conform to the targeted cardiac tissue architecture (e.g. atrial, ventricle, right ventricular outflow tract, coronary sinus, pulmonary veins, etc.) corresponding to the specific type of cardiac arrhythmia. The present invention can precisely locate the source of arrhythmia as described above and deliver therapy from the same electrode array. This is achieved using a capacitive sensing electrode array that can not only monitor but also deliver electrical stimulation.

Devices, systems, and methods for closing the base of a left atrial appendage or other tissue structure comprise a device applicator having jaws, a shaft, and a handle. First and second triggers on a handle are configured to close the jaws and a closure device in a step-wise manner where tissue penetrating fasteners within the closure device are engaged by studs on the jaws, where the studs must be released prior to the opening of the jaws.

The disclosed embodiments provide a method for acquiring MR data at resolutions down to tens of microns for application in in-vivo diagnosis and monitoring of pathology for which changes in fine tissue textures can be used as markers of disease onset and progression. Bone diseases, tumors, neurologic diseases, and diseases involving fibrotic growth and/or destruction are all target pathologies. Further the technique can be used in any biologic or physical system for which very high-resolution characterization of fine scale morphology is needed. The method provides rapid acquisition of selected values in k-space, with multiple successive acquisitions of individual k-values taken on a time scale on the order of microseconds, within a defined tissue volume, and subsequent combination of the multiple measurements in such a way as to maximize SNR. The reduced acquisition volume, and acquisition of only select values in k-space along selected directions, enables much higher in-vivo resolution than is obtainable with current MRI techniques.

An apparatus, method and system comprising an imaging tool for imaging an interventional device and its target organ using Doppler ultrasound are disclosed. The apparatus comprises an imaging tool and an interventional medical device; in some embodiments the imaging tool itself may be an interventional device or may comprise components of the interventional device. The imaging tool comprises a vibratory transducer and a vibratable element. The vibratory transducer is energized to generate a vibration motion in the vibratable element at first imaging frequency, which in turn is capable of oscillating a target organ at a second imaging frequency, the imaging frequencies being detectable by an ultrasound imaging system with Doppler mode. In certain applications the vibratory transducer may be energized to vibrate at a therapeutic frequency to effect treatment of the target organ, for example to clear a lumenal or vascular stenosis or to penetrate a vascular occlusion.

The invention relates to the technical field of medical image processing, in particular to a gastric early cancer auxiliary diagnosis method based on a deep learning multi-model fusion technology, which comprises the following steps: S1, constructing multiple models; s2, collecting gastroscope images, forming continuous serialized image frames, identifying the light source mode of the current image frame by utilizing the image classification model 1, entering the step S3 to mark the position of a focus by the target detection model 2 when the current image frame is identified as a white lightmode, and marking the high-risk focus by utilizing the image classification model 3; and when the image frame is identified as the dyeing amplification mode, entering the step S4 in which a segment model group can extract the boundary range, the microvessel form and the micro-tissue structure feature map in the image frame in real time, and outputting whether canceration occurs or not, the credibility and the differentiation type by the decision-making model 7. A plurality of deep learning models are constructed according to different tasks, a parallel cascade model fusion technology is adopted, and a full-process intelligent auxiliary diagnosis function is provided in the stomach early cancer screening process of endoscopists.

In a method for treating an affected skin region of a patient having a skin disorder, a vasodilation composition is applied to an affected skin region of a patient, the affected skin region exhibiting a skin disorder characterized by at least one abnormal blood vessel, and the affected skin region is then treated so as to non-invasively disrupt tissue architecture, e.g., by inducing ischemia, of the at least one abnormal blood vessel. A vasoconstriction composition can then be applied to the skin region to cause vasoconstriction of the at least one blood vessel in order to promote healing.

The invention discloses a method for preparing a high-temperature NTC heat-sensitive resistance material. Pure Fe2O3, NiO, MnO2 and Cr2O3 are selected and analyzed, then the materials are sintered according to a chemical formula mixture ratio of Fe[1-x]Ni0.5Mn1.5CrxO4 (x is selected from 0 to 0.16), the unadulterated FeNi0.5Mn1.5O4 basically meets the using requirement as the high-temperature NTC heat-sensitive resistance material, and the adulteration of Cr shows higher material constant B value of about 6,000K and room temperature resistivity change range of 10 to 10 omega/centimeter and achieves the using requirement under high-temperature conditions. The tissue structure characteristics required in the application of the high-temperature NTC material comprise that: the adulteration of little Cr2O3 does not change a phase structure of a matrix, the system with the adulteration amount in a certain range forms a single spinel phase, and no second phase appears; the grain size of the adulterated sample is comparatively even, and the grain boundary growth is comparatively perfect and has no abnormal growing grains; and a sintered sample has low porosity and enough compactness.

The present invention relates to a cell construct cultured in vitro characterized in that it comprises (i) animal cells cultured in vitro in conditions ensuring formation of a three-dimensional tissue structure and (ii) an endogenous extracellular matrix in which said cells are imprisoned, and in that it comprises, among said cells, cells having a mineralization and/or ossification capacity. The invention is particularly useful in the fields of grafts and implantology (tissue reconstruction or repair), as well as in the pharmaceutical industry, for research on tissue and analysis of the toxic or beneficial profile of molecules capable of being used in pharmaceutics development and/or pharmaceutical compositions.

The invention discloses a silicosis treatment aerosol containing a human mesenchymal stem cell exosome extract and a preparation method thereof, wherein the main component of the aerosol is the high-concentration mesenchymal stem cell exosome extract. The mesenchymal stem cells can secrete various cell factors in the culture process, and the cell factors can penetrate into the basal layer of an inner membrane, promote tissue differentiation of the inner membrane, angiogenesis and growth of granulation tissues, promote regeneration and repair of damaged skin tissue structures, reduce generation of scar connective tissues and reduce bacterial infection and inflammatory reaction of wound surface tissues. According to the aerosol and the preparation method thereof, a method of continuous starvation of the mesenchymal stem cells is adopted, a high-concentration human mesenchymal extract can be obtained in a short period of time, and a big amount of stem cell exosomes can be separated from the mesenchymal extract by an exosome extractor. The aerosol containing the high-concentration mesenchymal stem cell exosome extract disclosed by the invention is suitable for the restoration and treatment of silicosis.

The invention discloses a whole breast subserial large slice preparation method. The method comprises the following steps of collecting a tumor sample; performing continuous parallel splitting to obtain sample blocks which are split in parallel; performing soaking and fixing in a neutral formaldehyde solution with the concentration of 4% for 24 hours; removing redundant fat tissues by clipping; performing continuous parallel cutting in parallel to an original slice again to form a slice shape; performing continuous fixing for 48 hours by using the neutral formaldehyde solution with the concentration of 4%; performing sequential dehydration by adopting gradient ethanol; performing transparency treatment by using xylene; performing wax dipping in an electric heating constant temperature incubator at 62-65 DEG C to obtain a paraffin pathological sample; and slicing the paraffin pathological sample by adopting a rotary paraffin slicing machine, wherein each sample block can be subjected toconventional pathological staining including HE through continuous slicing. The thickness of a large slice prepared with the method can reach the conventional slice thickness of 4-5 microns; the slice is complete in tissue structure, smooth, clean and free of folds and pollution; no slice stripping phenomenon occurs; the cell nucleoplasm proportion is clear; and a staining result is consistent with a conventional clinical staining result.